Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 07, 2021 at 12:44 pm EST
Share
Li Kang Biomedical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 456.720 million compared to TWD 483.297 million a year ago. Operating income was TWD 80.940 million compared to TWD 88.306 million a year ago. Net income was TWD 69.268 million compared to TWD 72.016 million a year ago. Basic earnings per share from continuing operations was TWD 3.12 compared to TWD 3.24 a year ago. Diluted earnings per share from continuing operations was TWD 3.1 compared to TWD 3.22 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
